1/15
Looks like no tags are added yet.
Anti-tubercular Agents
Drugs used specifically for the prevention and treatment of tuberculosis (TB).
Tuberculosis (TB)
An infectious disease caused by the bacterium Mycobacterium tuberculosis that primarily attacks the lungs, but can also affect other organs such as the brain, bones, and kidneys.
Macrophages
Large white blood cells (WBCs) that protect the body by engulfing and destroying harmful microorganisms, foreign particles, and dead cells.
Granuloma
A protective immune structure formed when the body surrounds Mycobacterium tuberculosis bacteria with immune cells in an attempt to contain the infection.
Acid-Fast Bacteria
Bacteria, such as Mycobacterium tuberculosis, that retain a laboratory stain even after being washed with acid-alcohol.
Pulmonary TB
The most common form of tuberculosis that affects the lungs and can spread through airborne particles when an infected person coughs, sneezes, or speaks.
Extrapulmonary TB
A form of tuberculosis that develops in organs outside the lungs, including the bones, kidneys, brain, and lymph nodes.
First-Line Anti-tubercular Drugs
The core medications commonly used to treat drug-sensitive tuberculosis: Rifampicin, Isoniazid (INH), Pyrazinamide, Ethambutol, and Streptomycin.
Second-Line Anti-tubercular Drugs
Alternative agents reserved for selected cases, particularly drug-resistant tuberculosis, including Ethionamide, Cycloserine, Para-aminosalicylic acid (PAS), Amikacin, Kanamycin, Levofloxacin, and Moxifloxacin.
Mycolic Acid
A type of fatty acid that constitutes a vital part of the Mycobacterium tuberculosis cell wall, providing structural strength, protection, and host survival capability.
Isoniazid (INH)
A synthetic first-line anti-tubercular prodrug (isonicotinic acid hydrazide) that kills actively multiplying Mycobacterium tuberculosis by preventing the synthesis of mycolic acid.
KatG
A bacterial enzyme inside Mycobacterium tuberculosis that activates the prodrug isoniazid into its active form.
InhA
A bacterial enzyme essential for mycolic acid synthesis that is inhibited by the activated isoniazid-NAD complex, leading to bacterial death.
Structure-Activity Relationship (SAR) of Isoniazid
The structural requirements for isoniazid's antimycobacterial activity, comprising an intact pyridine ring, a hydrazide group at the 4th (para) position, and an unblocked terminal amino group.

Hydrazide Group of Isoniazid
The -CONHNH2 functional group attached at the 4th (para) position of isoniazid